News

The AbSolute High Cap is based on modified silica and will capture both monoclonal and polyclonal antibodies from high titer and large volume feedstock. According to the company,

The data was published in the New England Journal of Medicine (NEJM). The Phase 3 STRIVE study evaluated 161 patients 12 years or older who received at least

The Phase II study included comparison of the safety, tolerability and pharmacokinetic profiles of PG-free melphalan intravenous formulation to the standard multiple myeloma treatment. The Captisol-enabled drug is

The injection is indicated to treat cancer and is administered intravenously, hindubusinessline.com reported. The drug in the strengths of 10 mg/ vial and 50 mg/ vial, received approval

Abbott filed suit against Perrigo on 31 October 2011 over patent infringement. Androgel 1.0% (testosterone gel 1.0%) is used in the treatment of adult males who have low

According to the company, the new system comprises 14 updates that provide improved patient safety measures and features. ExactaMix ACDs automatically compound multi-ingredient sterile doses, reducing the risk

Health Canada has granted Optimer priority review of the Dificid NDS, reducing the time to a potential regulatory approval in Canada. The NDS is based on the results

ISIS-GCGRRx blocks the glucagon receptor (GCGR) and reduces amount of glucose producing harmone in the liver – glucagon. Isis COO, CFO and secretary Lynne Parshall said their ISIS-GCGRRx

Morrissey will act as an executive for small-cap start-ups and as a medical professional for the growth of nutraceutical market. She served at medical and dental clinics and